by Benzinga Insights | Oct 13, 2026 | General
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 2.27% on an annualized basis producing an average annual return of 11.34%. Currently, Gilead Sciences has a market capitalization of $186.53 billion. Buying $100 In GILD: If an...
by Erica Kollmann | Oct 13, 2026 | General
OpenAI said Tuesday it found a “sophisticated recording device” hidden in one of its offices. It then used its own models to trace the device to an employee who had planted it a few days earlier, according to a post from OpenAI Newsroom on X. The ChatGPT maker sent...
by Benzinga Insights | Oct 13, 2026 | General
Apollo Global Management (NYSE:APO) has outperformed the market over the past 15 years by 4.16% on an annualized basis producing an average annual return of 17.36%. Currently, Apollo Global Management has a market capitalization of $70.40 billion. Buying $1000 In APO:...
by Benzinga Insights | Oct 13, 2026 | General
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 12.41% on an annualized basis producing an average annual return of 25.61%. Currently, Alnylam Pharmaceuticals has a market capitalization of $30.38 billion. Buying $1000 In...
by Benzinga Insights | Oct 13, 2026 | General
Hewlett Packard (NYSE:HPE) has outperformed the market over the past 5 years by 23.71% on an annualized basis producing an average annual return of 35.42%. Currently, Hewlett Packard has a market capitalization of $93.32 billion. Buying $100 In HPE: If an investor had...
Recent Comments